{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-029052","form_type":"8-K","ticker":"INFU","cik":"0001337013","company_name":"InfuSystem Holdings, Inc","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.014627+00:00","generated_at":"2026-05-20T01:09:33.102084+00:00","sec_items":["3.03","5.03","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"InfuSystem signs new CEO employment agreement with Carrie Lachance; $500K base, 200K PSUs, 128K options","bullets":["Base salary $500,000; annual bonus up to 100% of base based on performance targets set by Compensation Committee.","Grant of 200,000 performance-based restricted stock units (PSUs) with vesting tied to stock price targets through 2028.","Grant of 128,000 stock options vesting 25% per year over 4 years.","Severance: 12 months salary on involuntary termination; 18 months on change-of-control termination.","CEO transition from President/COO to President/CEO effective May 19, 2025; agreement dated May 29, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-029052","json":"https://secwatch.observer/filing/0001628280-25-029052.json","markdown":"https://secwatch.observer/filing/0001628280-25-029052.md","text":"https://secwatch.observer/filing/0001628280-25-029052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025029052/0001628280-25-029052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025029052/infu-20250529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:09:33.102084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b49ba8df60","claim":"Carrie Lachance changed role as President and Chief Executive Officer at InfuSystem Holdings, Inc.","evidence_excerpt":"The Second Amended Agreement reflects changes in Ms. Lachance’s compensation and other terms of employment in connection with her previously announced transition from President and Chief Operating Officer of the Company to President and Chief Executive Officer of the Company that occurred on May 19, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025029052/0001628280-25-029052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c2ceabade980eaab4db369d80329b95842fc753d","claim":"InfuSystem Holdings, Inc: Amended and Restated Certificate of Incorporation to remove obsolete blank check company provisions, designate exclusive forums, and limit officer liability under Delaware law (effective 2025-05-20).","evidence_excerpt":"On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware a Second Amended and Restated Certificate of Incorporation to implement the Charter Amendments, which became effective upon filing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025029052/0001628280-25-029052-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}